Fifth Third Bancorp
ARNA

Fifth Third Bancorp’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Fifth Third Bancorp’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-75
Closed -$1K – 2292
2017
Q1 		$1K Hold
75
– – ﹤0.01% 2072
2016
Q4 		$1K Hold
75
– – ﹤0.01% 2151
2016
Q3 		$1K Buy
+75
New +$1.24K ﹤0.01% 2175
2015
Q3 		– Sell
-150
Closed -$7K – 3051
2015
Q2 		$7K Hold
150
– – ﹤0.01% 2223
2015
Q1 		$7K Hold
150
– – ﹤0.01% 2148
2014
Q4 		$5K Hold
150
– – ﹤0.01% 2130
2014
Q3 		$6K Hold
150
– – ﹤0.01% 2145
2014
Q2 		$9K Hold
150
– – ﹤0.01% 2059
2014
Q1 		$9K Buy
+150
New +$9.95K ﹤0.01% 2021

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fifth Third Bancorp's ARNA Position: Q2 2017 in Review

Fifth Third Bancorp sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2017, closing a stake of 75 shares — an estimated $1K sold.

Fifth Third Bancorp first reported a position in ARNA in Q1 2014 and held it in 9 quarters. The position peaked at $9K in Q2 2014. 102 funds tracked by Wall St. Rank hold ARNA as of Q2 2017.

  • Fifth Third Bancorp reported no remaining Arena Pharmaceuticals Inc position as of Q2 2017 after selling out during the quarter.
  • Fifth Third Bancorp sold 75 Arena Pharmaceuticals Inc shares in Q2 2017, an estimated $1K.
  • Fifth Third Bancorp first reported a position in Arena Pharmaceuticals Inc in Q1 2014 and held it in 9 quarters.
  • Fifth Third Bancorp's Arena Pharmaceuticals Inc position peaked at $9K in Q2 2014.
  • 102 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2017.

Based on Fifth Third Bancorp's 13F filing for Q2 2017, filed 11 Aug 2017.